Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML

Leukemia. 2010 Aug;24(8):1528-32. doi: 10.1038/leu.2010.124. Epub 2010 Jun 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Core Binding Factor Alpha 2 Subunit / genetics*
  • Female
  • Genes, ras*
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Myelodysplastic Syndromes / genetics*
  • Myeloid-Lymphoid Leukemia Protein / genetics*
  • Nuclear Proteins / genetics*
  • Nucleophosmin
  • fms-Like Tyrosine Kinase 3 / genetics*

Substances

  • Core Binding Factor Alpha 2 Subunit
  • KMT2A protein, human
  • NPM1 protein, human
  • Nuclear Proteins
  • RUNX1 protein, human
  • Nucleophosmin
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3